Dr. Jeffrey Morgan and Team Invited to Speak at 2019 International Society of Heart and Lung Transplant (ISHLT) Annual Meeting

An experienced cardiothoracic surgeon, Dr. Jeffrey Morgan is the Surgical Director of the Advanced Heart Failure Center of Excellence at Baylor College of Medicine. He specializes in treating patients with advanced heart and lung failure.

ORLANDO, FL / ACCESSWIRE / May 9, 2019 / Dr. Jeffrey Morgan and his team recently presented nine research projects at the 2019 ISHLT Annual Conference in Orlando, Florida. Thousands of physicians and other health experts attended the meeting. Dr. Jeffrey Morgan and his team presented their research on the following topics:

  • Magnitude of Bleeding and Blood Product Utilization Predict Early Right Ventricular Implantation in LVAD Recipients;
  • Predictors and Impact of Vasoplegia After Continuous-Flow Left Ventricular Assist Device Implantation;
  • Impact of Elevated Preoperative Blood Urea Nitrogen (BUN) Levels on Outcomes in CF-LVAD Patients;
  • Gastrointestinal Bleeding Ceases After Heart Transplantation in Patients Bridged on Continuous-Flow LVAD Support;
  • NTERMACS Profile Does Not Predict Required Flow Rate of CF-LVAD At Discharge;
  • Outcomes of LVAD Implantation in Ischemic Versus Nonischemic Cardiomyopathy;
  • Novel Oral Anticoagulants in Patients with Continuous Flow Left Ventricular Assist Devices;
  • Prediction of GIB using R2 CHA2DS2 VASc Risk Score and;
  • Different Risk Factors for Ischemic and Hemorrhagic Stroke on Continuous Flow.

ISHLT is a not for profit, multi-disciplinary, professional organization focused on improving care for patients with advanced heart or lung disease. Its mission is accomplished through transplantation, mechanical support, research, education and advocacy.

Founded in 1981, ISHLT now has over 3,800 members from over 45 countries. Its multi-disciplinary approach to treatment of advanced heart and lung disease has made it one of the most recognized organizations of its kind in the world. Its membership is made up of anesthesiologists, pharmacists, pulmonologists, tissue engineers, transplant coordinators, infectious disease specializes and others – all focused on the advancement of the science and treatment of heart and lung disease.

For more information about ISHLT, please visit https://ishlt.org/.

ABOUT DR. JEFFREY MORGAN

Dr. Jeffrey Morgan began his career as a cardiothoracic surgeon, after completing his residency at NYU in 2007. Dr. Jeffrey Morgan currently specializes in heart transplants
and LVAD surgeries. His main goal is to continue to search for new and inventive ways to make these surgeries more efficient and less invasive to the individual undergoing the surgery. He is constantly striving to help people and make a difference to their everyday lives wherever possible.

Dr. Jeffrey Morgan and his team of doctors are consistently promoting the importance of living a healthy heart lifestyle; through exercise, good dietary decisions, getting good sleep and weight loss. The team is currently traveling to various medical conferences and presenting their research projects.

For more information or to contact Dr. Jeffrey Morgan, please visit https://ishlt.org/.

Contact:

Dr. Jeffrey Morgan, Surgical Director of the Advanced Heart Failure Center of Excellence at Baylor College of Medicine
info@drjeffreymorgan.live

SOURCE: Dr. Jeffrey Morgan

View source version on accesswire.com:
https://www.accesswire.com/544837/Dr-Jeffrey-Morgan-and-Team-Invited-to-Speak-at-2019-International-Society-of-Heart-and-Lung-Transplant-ISHLT-Annual-Meeting

user

Recent Posts

Ascentiz Unveiled Modular Designed Exoskeleton at CES 2026: A Technical Deep Dive into Biomechanical Intelligence

The world's first modular exoskeleton combines quasi-direct-drive hip and cable-drive knee technologies for natural, powerful…

5 hours ago

From Clinical Recovery to Lifelong Empowerment: RoboCT Showcases Integrated Ecosystem Strategy at CES 2026

Leveraging Medical Robotics Heritage, the Company Expands into Consumer Market, Envisioning Exoskeletons as Integral 'New…

5 hours ago

Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs

The consolidated entity will leverage AI and precision engineering to create a comprehensive ecosystem advancing…

5 hours ago

Flo Health’s App Wins Google Play “Best of 2025” Award for Best for Watches in Hong Kong, Taiwan, and Macau

LONDON, Jan. 9, 2026 /PRNewswire/ -- Flo Health, the company behind the globally trusted Flo…

5 hours ago

Gifthealth Celebrates Grand Opening Of New Pharmacy In Mesa

MESA, Ariz., Jan. 9, 2026 /PRNewswire/ -- Gifthealth, a unified digital pharmacy platform, today celebrated the…

5 hours ago

Lucent Health Names Aadam Hussain as Chief Executive Officer Following Brett Rodewald’s Retirement

NASHVILLE, Tenn., Jan. 9, 2026 /PRNewswire/ -- Today, Lucent Health, one of the nation's largest independent…

5 hours ago